Literature DB >> 19298294

Age-related efficacy of parathyroid hormone on osseointegration in the rat.

Birgit Mair1, Stefan Tangl, Johannes Feierfeil, Daniela Skiba, Georg Watzek, Reinhard Gruber.   

Abstract

OBJECTIVE: Aging is a physiological determinant that can distinguish the outcome of a pharmaceutical therapy to improve osseointegration of titanium implants. Here we examined the possible interaction of intermittent parathyroid hormone (PTH) and the age of the recipient on the parameters of osseointegration in a rat tibia implantation model.
MATERIAL AND METHODS: Twenty female Wistar rats aged 8 months and 20 female rats aged 2 months received PTH at 60 microg/kg body weight or a vehicle by a subcutaneous injection three times a week. After 4 weeks, histomorphometric analysis of the peri-implant area was performed. The possible interaction of the two factors on 'bone volume per tissue volume' (BV/TV) and 'bone-to-implant contact' (BIC) was tested by two-way analysis of variance.
RESULTS: Based on data from the medullary compartment, two-way analysis of variance revealed that the effect of 'intermittent PTH' depends on the 'age of the recipient' when BV/TV is considered the dependent variable (P=0.04). Post hoc tests indicated that PTH leads to an increase of BV/TV of adult and young rats. However, when BIC was considered the dependent variable, no interaction was observed (P=0.14). PTH but not aging has a significant impact on BIC. In the cortical compartment, no effects of PTH on osseointegration were observed.
CONCLUSIONS: The findings indicate that treatment with PTH is more effective on the peri-implant bone regeneration in adult than in young animals, supporting the importance to consider the influences of age on the development of pharmaceutical therapies to increase the process of osseointegration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298294     DOI: 10.1111/j.1600-0501.2008.01658.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  6 in total

Review 1.  Efficacy of parathyroid hormone supplementation on the osseointegration of implants: a systematic review.

Authors:  Fawad Javed; Mohammad D Al Amri; Sergio Varela Kellesarian; Abdulaziz A Al-Kheraif; Fahim Vohra; José Luis Calvo-Guirado; Hans Malmstrom; Georgios E Romanos
Journal:  Clin Oral Investig       Date:  2015-12-22       Impact factor: 3.573

2.  Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.

Authors:  Y F Li; X D Li; C Y Bao; Q M Chen; H Zhang; J Hu
Journal:  Osteoporos Int       Date:  2013-01-08       Impact factor: 4.507

3.  The combined effect of parathyroid hormone and bone graft on implant fixation.

Authors:  H Daugaard; B Elmengaard; T T Andreassen; J Baas; J E Bechtold; K Soballe
Journal:  J Bone Joint Surg Br       Date:  2011-01

4.  Parathyroid hormone treatment increases fixation of orthopedic implants with gap healing: a biomechanical and histomorphometric canine study of porous coated titanium alloy implants in cancellous bone.

Authors:  Henrik Daugaard; Brian Elmengaard; Troels Andreassen; Joan Bechtold; Anders Lamberg; Kjeld Soballe
Journal:  Calcif Tissue Int       Date:  2011-01-21       Impact factor: 4.333

Review 5.  Hormone and implant osseointegration: Elaboration of the relationship among function, preclinical, and clinical practice.

Authors:  Ming Yi; Ying Yin; Jiwei Sun; Zeying Wang; Qingming Tang; Cheng Yang
Journal:  Front Mol Biosci       Date:  2022-09-15

6.  Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in a Rat Model.

Authors:  Faez Saleh Al-Hamed; Ola M Maria; Jeff Phan; Ahmed Al Subaie; Qiman Gao; Alaa Mansour; Lina Abu Nada; Imane Boukhatem; Osama A Elkashty; Simon D Tran; Marie Lordkipanidzé; Zahi Badran; Faleh Tamimi
Journal:  Biomolecules       Date:  2020-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.